Literature DB >> 34150001

Efficient antigen cross-presentation through coating conventional aluminum adjuvant particles with PEI.

Hongyan Ren1,2, Yongbin Mou2,3, Lin Lin2,4, Lixin Wang5, Hongming Hu2.   

Abstract

Classical aluminum adjuvant is a deficient antigen carrier for cross-presentation and cross-priming of CD8+ cytotoxic T cells. Our previous research has demonstrated that cross-presentation efficiency significantly increased when antigens are conjugated covalently to α-Al2O3 nanoparticles. Here we found that coating conventional aluminum adjuvants with polyethyleneimine (PEI) could enhance antigen cross-presentation of DCs (dendritic cells) in vitro and in vivo. PEIs exerted differential effects on antigen cross-presentation. These findings provided an alternative approach to promote the rapid translation of alumina nanoparticles adjuvants into clinical application. AJTR
Copyright © 2021.

Entities:  

Keywords:  Aluminum adjuvant; PEI; antigen cross-presentation; dendritic cells

Year:  2021        PMID: 34150001      PMCID: PMC8205809     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  38 in total

1.  ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells.

Authors:  Pierre Guermonprez; Loredana Saveanu; Monique Kleijmeer; Jean Davoust; Peter Van Endert; Sebastian Amigorena
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

Review 2.  TLR signalling regulated antigen presentation in dendritic cells.

Authors:  Colin Watts; Michele A West; Rossana Zaru
Journal:  Curr Opin Immunol       Date:  2010-01-18       Impact factor: 7.486

3.  A viral deubiquitylating enzyme restores dislocation of substrates from the endoplasmic reticulum (ER) in semi-intact cells.

Authors:  Sumana Sanyal; Jasper H L Claessen; Hidde L Ploegh
Journal:  J Biol Chem       Date:  2012-05-22       Impact factor: 5.157

4.  STAT2 Is Required for TLR-Induced Murine Dendritic Cell Activation and Cross-Presentation.

Authors:  Jun Xu; Michael H Lee; Marita Chakhtoura; Benjamin L Green; Kevin P Kotredes; Robert W Chain; Uma Sriram; Ana M Gamero; Stefania Gallucci
Journal:  J Immunol       Date:  2016-05-27       Impact factor: 5.422

Review 5.  Cross-Presentation in Mouse and Human Dendritic Cells.

Authors:  Elodie Segura; Sebastian Amigorena
Journal:  Adv Immunol       Date:  2015-04-08       Impact factor: 3.543

Review 6.  Taking dendritic cells into medicine.

Authors:  Ralph M Steinman; Jacques Banchereau
Journal:  Nature       Date:  2007-09-27       Impact factor: 49.962

7.  Dendritic cells require NIK for CD40-dependent cross-priming of CD8+ T cells.

Authors:  Anand K Katakam; Hans Brightbill; Christian Franci; Chung Kung; Victor Nunez; Charles Jones; Ivan Peng; Surinder Jeet; Lawren C Wu; Ira Mellman; Lélia Delamarre; Cary D Austin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-11       Impact factor: 11.205

8.  Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA delivery in vitro and in vivo.

Authors:  Petro Zhupanyn; Alexander Ewe; Thomas Büch; Anastasia Malek; Phil Rademacher; Claudia Müller; Anja Reinert; Yarúa Jaimes; Achim Aigner
Journal:  J Control Release       Date:  2019-12-19       Impact factor: 9.776

9.  Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response.

Authors:  Haiyan Li; Yuhuan Li; Jun Jiao; Hong-Ming Hu
Journal:  Nat Nanotechnol       Date:  2011-09-18       Impact factor: 39.213

Review 10.  Particulate adjuvant and innate immunity: past achievements, present findings, and future prospects.

Authors:  Etsushi Kuroda; Cevayir Coban; Ken J Ishii
Journal:  Int Rev Immunol       Date:  2013-04       Impact factor: 5.311

View more
  1 in total

Review 1.  Vaccine adjuvants to engage the cross-presentation pathway.

Authors:  Woojong Lee; M Suresh
Journal:  Front Immunol       Date:  2022-08-01       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.